Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review BM Mathers, L Degenhardt, B Phillips, L Wiessing, M Hickman, ... The Lancet 372 (9651), 1733-1745, 2008 | 1519 | 2008 |
HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage BM Mathers, L Degenhardt, H Ali, L Wiessing, M Hickman, RP Mattick, ... The Lancet 375 (9719), 1014-1028, 2010 | 758 | 2010 |
Psychological and social sequelae of cannabis and other illicit drug use by young people: a systematic review of longitudinal, general population studies J Macleod, R Oakes, A Copello, I Crome, M Egger, M Hickman, ... The Lancet 363 (9421), 1579-1588, 2004 | 737 | 2004 |
Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta‐analysis of cohort studies L Degenhardt, C Bucello, B Mathers, C Briegleb, H Ali, M Hickman, ... Addiction 106 (1), 32-51, 2011 | 733 | 2011 |
Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review L Degenhardt, A Peacock, S Colledge, J Leung, J Grebely, P Vickerman, ... The Lancet Global Health 5 (12), e1192-e1207, 2017 | 623 | 2017 |
Meningococcal carriage by age: a systematic review and meta-analysis H Christensen, M May, L Bowen, M Hickman, CL Trotter The Lancet infectious diseases 10 (12), 853-861, 2010 | 534 | 2010 |
Global overview of injecting drug use and HIV infection among injecting drug users C Aceijas, GV Stimson, M Hickman, T Rhodes Aids 18 (17), 2295-2303, 2004 | 526 | 2004 |
Hepatitis C virus treatment for prevention among people who inject drugs: modeling treatment scale‐up in the age of direct‐acting antivirals NK Martin, P Vickerman, J Grebely, M Hellard, SJ Hutchinson, VD Lima, ... Hepatology 58 (5), 1598-1609, 2013 | 513 | 2013 |
Prevention of HIV infection for people who inject drugs: why individual, structural, and combination approaches are needed L Degenhardt, B Mathers, P Vickerman, T Rhodes, C Latkin, M Hickman The Lancet 376 (9737), 285-301, 2010 | 456 | 2010 |
Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol … R Williams, R Aspinall, M Bellis, G Camps-Walsh, M Cramp, A Dhawan, ... The Lancet 384 (9958), 1953-1997, 2014 | 452 | 2014 |
Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis GJ MacArthur, S Minozzi, N Martin, P Vickerman, S Deren, J Bruneau, ... Bmj 345, 2012 | 409 | 2012 |
Mortality among people who inject drugs: a systematic review and meta-analysis BM Mathers, L Degenhardt, C Bucello, J Lemon, L Wiessing, M Hickman Bulletin of the World Health Organization 91, 102-123, 2013 | 382 | 2013 |
The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence KME Turner, S Hutchinson, P Vickerman, V Hope, N Craine, N Palmateer, ... Addiction 106 (11), 1978-1988, 2011 | 358 | 2011 |
Global statistics on alcohol, tobacco and illicit drug use: 2017 status report A Peacock, J Leung, S Larney, S Colledge, M Hickman, J Rehm, ... Addiction 113 (10), 1905-1926, 2018 | 336 | 2018 |
Risk of death during and after opiate substitution treatment in primary care: prospective observational study in UK General Practice Research Database R Cornish, J Macleod, J Strang, P Vickerman, M Hickman Bmj 341, 2010 | 304 | 2010 |
Combination interventions to prevent HCV transmission among people who inject drugs: modeling the impact of antiviral treatment, needle and syringe programs, and opiate … NK Martin, M Hickman, SJ Hutchinson, DJ Goldberg, P Vickerman Clinical Infectious Diseases 57 (suppl_2), S39-S45, 2013 | 296 | 2013 |
Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis EJ Aspinall, D Nambiar, DJ Goldberg, M Hickman, A Weir, E Van Velzen, ... International journal of epidemiology 43 (1), 235-248, 2014 | 293 | 2014 |
Can antiviral therapy for hepatitis C reduce the prevalence of HCV among injecting drug user populations? A modeling analysis of its prevention utility NK Martin, P Vickerman, GR Foster, SJ Hutchinson, DJ Goldberg, ... Journal of hepatology 54 (6), 1137-1144, 2011 | 287 | 2011 |
Interventions to prevent HIV and hepatitis C in people who inject drugs: a review of reviews to assess evidence of effectiveness GJ MacArthur, E van Velzen, N Palmateer, J Kimber, A Pharris, V Hope, ... International Journal of Drug Policy 25 (1), 34-52, 2014 | 286 | 2014 |
Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a … N Palmateer, J Kimber, M Hickman, S Hutchinson, T Rhodes, D Goldberg Addiction 105 (5), 844-859, 2010 | 282 | 2010 |